Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check24 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
- Check38 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top element.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and specific locations in Washington D.C. and St. Louis, while also removing various terms related to genetic diseases and pharmacological classifications.SummaryDifference2%
- Check67 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.